Vital

When the medication isn't working

Ozempic Not Working? Timelines, Doses, and Next Steps

If Ozempic seems not to be working for blood sugar or weight, the cause is often the dose step, the time frame, or what you measure. Here is how to check each one and what to bring to your prescriber.

Last reviewed

The Vital angle

Vital keeps a dated record of every Ozempic dose with the amount, injection site, and any symptoms you tag, so missed weeks and time on each dose step are easy to see. Weight and blood glucose from Apple Health sit next to that dose history, which gives your prescriber a clear picture instead of a guess.

If you feel that Ozempic is not working, you are not alone, and the feeling is often early. Ozempic (semaglutide injection) starts at a low dose that is meant to help your body adjust, not to show full results. Before you decide that "Ozempic not working" describes your situation, it helps to know what the label says to expect, how long each step takes, and which results it was approved to change.

This guide covers blood sugar and weight separately, because the answer is different for each. It does not replace your prescriber. Any change to your dose, schedule, or medication is a decision for them.

What Ozempic is approved to do

Ozempic is approved in the United States for adults with type 2 diabetes. Its label lists three uses: to improve blood sugar control alongside diet and exercise, to lower the risk of major cardiovascular events in people with type 2 diabetes and heart disease, and to lower the risk of kidney decline in people with type 2 diabetes and chronic kidney disease.

It is not approved as a weight loss medication. Weight loss happens for many people who take it, and the label reports it, but the doses were chosen for blood sugar. The same molecule at higher doses is sold as Wegovy for weight management. If weight is your main goal, that difference matters, and it is worth reading Wegovy not working as well.

Why the first weeks can feel like nothing is happening

The label sets a slow start on purpose:

  1. Weeks 1 to 4: 0.25 mg once a week.
  2. Week 5 onward: 0.5 mg once a week.
  3. If more blood sugar control is needed, 1 mg after at least 4 weeks at 0.5 mg.
  4. If still more control is needed, 2 mg after at least 4 weeks at 1 mg.

The 0.25 mg step is there to lower the chance of nausea and other stomach side effects while your body adjusts. Many people notice less hunger in the first month and then feel that effect fade, or never notice it at all. Neither pattern means the medication failed. It often means you are still on a starting dose. For a broader look at the first weeks on any of these drugs, see GLP-1 not working in the first month.

If your blood sugar is not improving

Blood sugar is the main thing Ozempic is meant to change, so it is the best place to judge it.

In the label's 30-week trial of Ozempic used alone, average A1C fell by 1.4 points at 0.5 mg and 1.6 points at 1 mg, compared with 0.1 points on placebo. About 7 in 10 people on Ozempic reached an A1C under 7 percent. These are averages. Some people saw more change and some saw less.

Keep the time frame in mind. The NIDDK explains that an A1C test reflects your average blood sugar over the past 3 months. An A1C drawn six weeks after you started will still include many weeks from before Ozempic, and most of that time was on the starting dose.

Useful questions to bring to your prescriber:

  • What dose am I on now, and is there a next step on the label for me?
  • When should we recheck A1C so the result reflects time on a full dose?
  • Do my home glucose readings (fasting and after meals) show a trend yet?
  • Have any of my other medicines, illnesses, or steroid courses changed recently?

If you also take insulin or a sulfonylurea, your prescriber may adjust those doses, because the label warns about a higher risk of low blood sugar when they are combined. Do not change them on your own.

If your weight is not changing

Weight loss on Ozempic is real but usually smaller than what you see in headlines. In the same 30-week trial, average weight change was about 3.8 kg at 0.5 mg and 4.7 kg at 1 mg, compared with 1.2 kg on placebo. The larger numbers people quote often come from Wegovy trials, which used semaglutide 2.4 mg for 68 weeks in people without diabetes.

People with type 2 diabetes also tend to lose less weight on these drugs than people without it, which the Wegovy label shows when it compares its trials. If you compare your result to a friend who takes a different product for a different reason, the gap can look like failure when it is not.

Before you decide the weight result is poor, check these:

  1. Measure the right way. Weigh yourself at the same time of day, in similar clothes, and look at a 4-week trend rather than single days. Water and sodium can move the scale by 1 to 3 pounds overnight.
  2. Note your dose history. If you spent two months at 0.25 mg and 0.5 mg, that is most of your time on the drug so far.
  3. Look at what you eat when hunger is lower. Less hunger can still leave room for calorie-dense drinks, snacks, and alcohol.
  4. Protect muscle. Enough protein and some resistance work help keep lean mass while you lose fat. See protein on GLP-1.

If weight loss stalls after a good start, weight loss plateaus explains the normal pattern and what helps.

Practical problems that can reduce the effect

Some issues have nothing to do with how your body responds and everything to do with the pen or the routine.

  • Missed or late doses. The label gives a 5-day window to take a missed dose, and it says what to do after that window. Ask your pharmacist if you are not sure which rule applies to you. Gaps can bring back hunger and blood sugar spikes. See missed GLP-1 dose.
  • Storage. Before first use, keep the pen in the refrigerator. After first use, the label allows 56 days at 59°F to 86°F or in the refrigerator. Do not freeze it. If a pen got too hot or froze, ask your pharmacist whether to replace it. See GLP-1 left out of the fridge.
  • Pen use. Check the dose counter and hold the pen against the skin as the instructions say. If the pen does not seem to click or deliver, read Ozempic pen not clicking.
  • Product source. The FDA warns that some compounded semaglutide products use salt forms, such as semaglutide sodium or acetate, which are different active ingredients from the approved drug, and it has reports of dosing errors when people measure compounded injections themselves. A brand-name Ozempic pen from a licensed pharmacy removes that variable. See compounded vs brand semaglutide.

When to talk to your prescriber, and what to bring

Plan a visit if any of these apply:

  • You have been on a full dose for about 3 months and your A1C has not moved.
  • You had a good early response, and blood sugar is now rising again on the same dose.
  • Side effects are stopping you from reaching or keeping the next dose.
  • Your main goal is weight, and you want to discuss whether a weight management product fits you better.

Bring a short, honest record: the date and dose of each injection, any missed weeks, recent glucose readings, a weight trend, and side effects with how bad they were. That record lets your prescriber tell the difference between "not enough time," "not enough dose," "doses were missed," and "this drug is not a good fit." The options after that, such as a dose change, a different medication like tirzepatide, or extra diabetes medicines, are theirs to weigh. If tirzepatide comes up, switching semaglutide to tirzepatide explains what usually changes.

Warning signs that need care now

Do not wait for your next visit if you have:

  • Severe stomach pain that does not go away, with or without vomiting. The label lists this as a possible sign of pancreatitis.
  • Pain in the upper right belly, fever, yellow skin or eyes, or clay-colored stool, which can point to gallbladder problems.
  • Signs of a serious allergic reaction: swelling of the face, lips, tongue, or throat, trouble breathing or swallowing, a fast heartbeat, or a severe rash.
  • Symptoms of low blood sugar such as shaking, sweating, confusion, or a fast heartbeat, especially if you also use insulin or a sulfonylurea.
  • Very little urine, or vomiting and diarrhea that make you unable to keep fluids down, because dehydration can harm the kidneys.
  • Changes in vision if you have diabetic eye disease.
  • A lump or swelling in the neck, trouble swallowing, or hoarseness that does not go away.

Call your prescriber or get emergency care for these. A slow response to Ozempic is a planning question. These symptoms are not.


Ozempic®, Wegovy® are trademarks of Novo Nordisk A/S. Vital is independent and not affiliated with these companies.

Free toolGLP-1 medication level chart

Things to watch

Practical flags drawn from prescribing information and clinical guidance. Vital surfaces these in the dose log to help you spot them early.

  • Judging results on the 0.25 mg starting dose

    The label uses 0.25 mg for the first 4 weeks so your body can adjust. Most of the blood sugar and weight effect comes at later dose steps, so a weak first month says little about the final result.

  • Rechecking A1C too soon

    An A1C test reflects about 3 months of blood sugar. A test drawn a few weeks after you start still includes time before Ozempic and time on the starting dose.

  • Comparing Ozempic weight loss to Wegovy headlines

    The 15 percent figures come from semaglutide 2.4 mg in people without diabetes. Ozempic doses are lower and are approved for type 2 diabetes, so average weight loss in its trials was smaller.

  • Missed doses past the 5-day window

    The label gives a 5-day window to take a missed dose. Repeated gaps can let hunger and blood sugar rise again and make the drug look like it stopped working.

  • Compounded semaglutide of uncertain form

    The FDA warns that some compounded products use semaglutide salt forms that differ from the approved ingredient, and it has reports of dosing errors when people measure compounded injections themselves.

  • Severe, lasting stomach pain

    The label lists severe stomach pain that does not go away, with or without vomiting, as a possible sign of pancreatitis. Get medical care right away.

Frequently asked questions

  • Ozempic starts at 0.25 mg for 4 weeks, then 0.5 mg, with possible steps to 1 mg and 2 mg after at least 4 weeks each. Some people notice less hunger early, but blood sugar results are best judged with an A1C after about 3 months, ideally with most of that time on a full dose.

  • Common reasons are time spent on low starting doses, missed doses, and comparing results to Wegovy trials that used a higher dose in people without diabetes. In the Ozempic monotherapy trial, average weight loss was about 3.8 to 4.7 kg at 30 weeks. Ask your prescriber whether your dose and goals match.

  • First check the timing: an A1C reflects about 3 months, so an early test may not show the full effect. Then bring your dose history, missed doses, and home glucose readings to your prescriber, who can decide whether a dose step, another medicine, or a different approach makes sense.

  • Weight loss often slows after the first months, which is a normal plateau. Blood sugar that rises again on a stable dose is worth reporting, because illness, other medicines, missed doses, or changes in diabetes itself can be the cause.

  • Do not change your dose on your own. The label allows steps to 1 mg and 2 mg after at least 4 weeks on the current dose when more blood sugar control is needed, and your prescriber decides if and when that fits you.

  • The FDA has not approved compounded semaglutide, and it warns that some products use salt forms that are different active ingredients. If you use a compounded product and results seem weak, tell your prescriber what you use.

Sources

  1. OZEMPIC (semaglutide) injection Prescribing Information · Novo Nordisk
  2. How to Use Ozempic Pen · Novo Nordisk
  3. The A1C Test & Diabetes · NIDDK, National Institutes of Health
  4. WEGOVY (semaglutide) Prescribing Information · Novo Nordisk
  5. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss · U.S. Food and Drug Administration

This page summarizes publicly available information from the sources listed above and is for educational use only. It is not medical advice. Consult a qualified healthcare professional for personal dosing guidance.

Track every shot, every change

Vital logs every GLP-1 injection and peptide dose, then surfaces patterns your scale can't show. Free on iOS and Android.